Abstract

BackgroundSchizophrenia is a complex genetic disorder caused by multiple genetic and environmental factors. The dystrobrevin-binding protein 1 (DTNBP1: dysbindin-1) gene is a major susceptibility gene for schizophrenia. Genetic variations in DTNBP1 are associated with cognitive functions, general cognitive ability and memory function, and clinical features of patients with schizophrenia including negative symptoms and cognitive decline. Since reduced expression of dysbindin-1 has been observed in postmortem brains of patients with schizophrenia, the sandy (sdy) mouse, which has a deletion in the Dtnbp1 gene and expresses no dysbindin-1 protein, could be an animal model of schizophrenia. To address this issue, we have carried out a comprehensive behavioral analysis of the sdy mouse in this study.ResultsIn a rotarod test, sdy mice did not exhibit motor learning whilst the wild type mice did. In a Barnes circular maze test both sdy mice and wild type mice learned to selectively locate the escape hole during the course of the training period and in the probe trial conducted 24 hours after last training. However, sdy mice did not locate the correct hole in the retention probe tests 7 days after the last training trial, whereas wild type mice did, indicating impaired long-term memory retention. A T-maze forced alternation task, a task of working memory, revealed no effect of training in sdy mice despite the obvious effect of training in wild type mice, suggesting a working memory deficit.ConclusionSdy mouse showed impaired long-term memory retention and working memory. Since genetic variation in DTNBP1 is associated with both schizophrenia and memory function, and memory function is compromised in patients with schizophrenia, the sdy mouse may represent a useful animal model to investigate the mechanisms of memory dysfunction in the disorder.

Highlights

  • Schizophrenia is a complex genetic disorder caused by multiple genetic and environmental factors

  • dystrobrevin-binding protein 1 (DTNBP1) risk haplotypes for schizophrenia have been associated with decreased gene expression, whereas DTNBP1 protective haplotypes for the disorder have been associated with increased gene expression [7]

  • Chronic treatment of mice with antipsychotics was not found to affect the expression levels of dysbindin-1 protein and mRNA in their brains [6,8], suggesting that prior evidence of lower dysbindin-1 protein and mRNA levels in the postmortem brains of schizophrenics is not likely to be an artifact of antemortem drug treatment

Read more

Summary

Introduction

Schizophrenia is a complex genetic disorder caused by multiple genetic and environmental factors. Chronic treatment of mice with antipsychotics was not found to affect the expression levels of dysbindin-1 protein and mRNA in their brains [6,8], suggesting that prior evidence of lower dysbindin-1 protein and mRNA levels in the postmortem brains of schizophrenics is not likely to be an artifact of antemortem drug treatment. Together, these data indicate that the dysbindin-1 gene may confer susceptibility to schizophrenia through reduced expression

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.